Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ARVN: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ARVN
Arvinas, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ARVN
Arvinas, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
ARVN, dashed
Supply-chain overlap
Revenue flow
ARVN: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only ARVN
4
PFE
Pfizer
customer
NVS
Novartis Pharma
customer
—
Yale University
unlisted
supplier
—
Bayer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
customer
LLY
ELI Lilly & Co
Change
1,417.89
· pre 1,427.96
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ARVN
Arvinas, Inc.
Change
7.42
· pre 7.35
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$485.9M
Revenue
$500,000
Q3 FY26
Revenue
$263M
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
LLY
ELI Lilly & Co
vs
ARVN
Arvinas, Inc.
1,417.89
pre 1,427.96
delayed
Price
7.42
pre 7.35
delayed
$1.3T
Mkt cap
$485.9M
Q3 FY26
$24.4B
Revenue
$500,000
Q3 FY26
FY25
$65.2B
Revenue
$263M
FY25
Change
Change
LLY
1,417.89
vs
ARVN
7.42
Pre-market
Nov 5 '26
delayed